Insurance Mis-selling
Insurance mis-selling is the unethical practice of selling an insurance product through misrepresentation, concealment of material facts, or misleading communication — such as presenting a ULIP as a fixed-return instrument, omitting exclusions, or pressuring a customer into unsuitable products to earn commissions.
Insurance mis-selling was a persistent and widely documented problem in the Indian insurance market, attracting regulatory attention from IRDAI and periodic consumer complaints to banking and insurance ombudsmen. It arose from structural incentives: insurance agents and bancassurance channels earned commissions that were highest in the first year of a policy and on higher-premium products, creating pressure to sell complex, high-commission instruments to customers for whom they were not necessarily appropriate.
The most common forms of insurance mis-selling in India included misrepresenting ULIPs as fixed-return investment products without adequately disclosing market risk; presenting endowment or money-back plans as superior to PPF or FDs without disclosing the low internal rates of return; concealing medical exclusions in health insurance policies or claiming coverage that did not exist; selling insurance to senior citizens on misleading representations about death benefit structures; and using bank customer relationships to pressure account holders into purchasing insurance products to avoid charges or obtain loan approvals.
IRDAI addressed mis-selling through several regulatory instruments. The 2008 ULIP advertisement and disclosure regulations required issuers to include specific risk disclaimers. The 2010 ULIP restructuring reduced front-loaded charges that had made ULIPs particularly prone to mis-selling (since early surrender after mis-selling destroyed most of the premium paid). The Insurance Repository system and the policy document standardisation requirements improved disclosure quality. The free look period regulation gave consumers a statutory window to reverse a mis-sold policy without financial penalty.
Consumers who believed they had been mis-sold an insurance product had several recourse channels. The insurer's internal grievance redressal mechanism was the first port of call. If unresolved within 30 days, the complaint could be escalated to the Insurance Ombudsman — a IRDAI-established quasi-judicial body with jurisdiction over disputes up to Rs 50 lakh — at no cost to the complainant. IRDAI's Bima Bharosa portal and the consumer portal Bima Sugam (being rolled out as of 2024) were also regulatory channels for complaints.
The prevention of mis-selling ultimately required financial literacy on the buyer's side alongside regulatory enforcement on the seller's side. An informed buyer who understood the difference between insurance and investment, read policy documents before signing, asked for benefit illustrations showing net-of-charges returns, and was aware of the free look period was significantly less vulnerable to mis-selling practices.